Functional wound dressing

US2021361822A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021361822-A1
Application numberUS-201917055341-A
CountryUS
Kind codeA1
Filing dateMay 13, 2019
Priority dateMay 14, 2018
Publication dateNov 25, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a functional wound dressing being able to detect and indicate the state of the wound, in particular with regard to infections for example caused by toxins produced by bacteria such Staphylococcus aureus and Pseudomonas aeruginosa . The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound and to provide moisture to the wound.

First claim

Opening claim text (preview).

1 . A wound dressing comprising: a) a hydrogel selected from starch-based hydrogel, dextran-based hydrogel, alkyleneoxid-based hydrogel, cellulose-based hydrogel, pectin-based hydrogel, alginate-based hydrogel, chitosan-based hydrogel, hyaluronic acid-based hydrogel, gellan-based, polypeptide-based hydrogel, polyakyleneoixd-based hydrogel, poly(methacrylate)-based hydrogel, poly (alkyl(methacrylate)-based hydrogel, poly(ethacrylate)-based hydrogel, vinyl polymer based hydrogel, polycaprolactam- and polycaprolactone-based hydrogel, polyurethane-based hydrogel, polyurea-based hydrogel, polyurethane-polyurea-copolymer-based hydrogel and mixtures thereof; and b) a carrier containing fluorescent dye, wherein the hydrogel comprises a buffer, wherein the buffer after being dissolved in demineralized water at 37° C. forms a buffer solution having a pH value of 6.0 to 9.0. 2 . The wound dressing according to claim 1 , wherein the hydrogel is a polyurethane-based hydrogel. 3 . The wound dressing according to claim 1 , wherein the buffer comprises 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid. 4 . The wound dressing according to claim 1 , wherein the hydrogel contains substances which at 37° C. in demineralized water exhibit a pH value of less than 6, amphiphilic substances and/or alcohol in an amount of 0 to 10 weight percent. 5 . The wound dressing according to claim 4 , wherein the substances exhibiting a pH value of less than 6 in demineralized water at 37° C. comprise organic acids, enolic compounds, fatty acids and amino acids. 6 . The wound dressing according to claim 4 , wherein amphiphilic substances comprise polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether (Triton) and/or polyetheramine (Jeffamine). 7 . The wound dressing according to claim 4 , wherein the alcohol comprises diethylene glycol, dipropylene glycol and glycerol. 8 . The wound dressing according to claim 1 , wherein the carrier is a liposome. 9 . The wound dressing according to claim 8 , wherein the liposome comprises: a) at least one of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, 1,2-distearyl-sn-glycero-3-phosphocholine, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, 1,2-distearyl-sn-glycero-3-phosphoethanolamine and 10,12-tricosadiynoic acid; and b) a sterol. 10 . The wound dressing according to claim 1 , wherein the fluorescent dye belongs to the group of xanthenes bearing at least one hydroxy group at the xanthene skeleton. 11 . The wound dressing according to claim 10 , wherein the fluorescent dye is fluorescein or carboxy fluorescein.

Assignees

Inventors

Classifications

  • Colorants, dyes · CPC title

  • A61L15/56Primary

    Wetness-indicators or colourants · CPC title

  • Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants · CPC title

  • Amino acids · CPC title

  • Liquid-swellable gel-forming materials, e.g. super-absorbents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021361822A1 cover?
The invention relates to a functional wound dressing being able to detect and indicate the state of the wound, in particular with regard to infections for example caused by toxins produced by bacteria such Staphylococcus aureus and Pseudomonas aeruginosa . The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound …
Who is the assignee on this patent?
Hartmann Paul Ag, Univ Bath
What technology area does this patent fall under?
Primary CPC classification A61L15/56. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).